MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Central Insulin Resistance Index is Independent of Peripheral Insulin Resistance in Parkinson’s disease

M. Tagliati, E. Hogg, T. Wu, K. Makwana, H. Maghzi, A. Garland, E. Tan, C. Riera (Los Angeles, CA, USA)

Meeting: 2019 International Congress

Abstract Number: 1786

Keywords: Neurophysiology, Parkinsonism, Resting brain metabolism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Physiology and Pathophysiology

Session Time: 1:15pm-2:45pm

Location: Les Muses, Level 3

Objective: To correlate brain insulin signalling with peripheral insulin resistance using neuronally derived blood exosomes in patients with Parkinson’s Disease (PD)

Background: Insulin signaling abnormalities may contribute to PD pathogenesis, both promoting and being driven by the deposition of alpha-synuclein. It is unknown whether peripheral insulin resistance and prediabetes are associated with dysfunctional central insulin signalling in PD. Extracellular Vesicles, or exosomes, can be separated to identify those that come specifically from brain neurons implicated in insulin resistance. While this method has primarily been used in AD, its utility has been proven in PD as well.

Method: Fasting insulin, fasting glucose, and HbA1c were recorded 37 non-diabetic and non-demented PD patients in order to determine peripheral IR status. IR was measured using the HOMA-IR method, defined as fasting glucose (mg/dl) × fasting insulin (mU/l)/405. HoMA-IR values ≥ 2.0 and/or HbA1c ≥5.7 were used to define peripheral IR. Plasma exosomes were precipitated and bound to a biotinylated CD-171 antibody, allowing to enrich for neuronal exosomes. This allowed for the determination of the ratio of pSer312-IRS-1 to pan-Tyr phosphorylated IRS-1 (IR index) for each subject. The significance of differences between PD patients with and without IR was calculated with non-parametric tests (Mann Whitney U).

Results: Of 37 non diabetic PD subjects included in the study, 18 (48.6%) had peripheral IR. Mean levels of P-serine 312-IRS-1 were 22.7 ± 0.86 U/ml in non-IR PD patients and 22.3 ± 0.89 U/ml in PD patients with IR (NS). P-pan-tyrosine-IRS-1 levels were 0.153 ± 0.06 AU (absorbance units at 450 nm) for non-IR PD and 0.156 ± 0.06 AU for PD with IR (NS). Mean IR index values were 159.2 ± 48.3 for PD with IR and 167.3 ± 55.1 for non-IR PD (NS).

Conclusion: Comparison of the results for PD patients with and without peripheral IR showed no differences in the exosomal levels of P-serine 312-IRS-1, P-pan-tyrosine-IRS-1, or IR index, suggesting that brain insulin resistance is independent of peripheral IR status in PD.

To cite this abstract in AMA style:

M. Tagliati, E. Hogg, T. Wu, K. Makwana, H. Maghzi, A. Garland, E. Tan, C. Riera. Central Insulin Resistance Index is Independent of Peripheral Insulin Resistance in Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/central-insulin-resistance-index-is-independent-of-peripheral-insulin-resistance-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/central-insulin-resistance-index-is-independent-of-peripheral-insulin-resistance-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley